Regulation of pancreatic islet gene expression in mouse islets by pregnancy. 2010

B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 15, Chicago, Illinois 60611, USA.

Pancreatic β cells adapt to pregnancy-induced insulin resistance by unclear mechanisms. This study sought to identify genes involved in β cell adaptation during pregnancy. To examine changes in global RNA expression during pregnancy, murine islets were isolated at a time point of increased β cell proliferation (E13.5), and RNA levels were determined by two different assays (global gene expression array and G-protein-coupled receptor (GPCR) array). Follow-up studies confirmed the findings for select genes. Differential expression of 110 genes was identified and follow-up studies confirmed the changes in select genes at both the RNA and protein level. Surfactant protein D (SP-D) mRNA and protein levels exhibited large increases, which were confirmed in murine islets. Cytokine-induced expression of SP-D in islets was also demonstrated, suggesting a possible role as an anti-inflammatory molecule. Complementing these studies, an expression array was performed to define pregnancy-induced changes in expression of GPCRs that are known to impact islet cell function and proliferation. This assay, the results of which were confirmed using real-time reverse transcription-PCR assays, demonstrated that free fatty acid receptor 2 and cholecystokinin receptor A mRNA levels were increased at E13.5. This study has identified multiple novel targets that may be important for the adaptation of islets to pregnancy.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled
D043886 Receptor, Cholecystokinin A A subtype of cholecystokinin receptor found primarily in the PANCREAS; STOMACH; INTESTINE; and GALLBLADDER. It plays a role in regulating digestive functions such as gallbladder contraction, pancreatic enzyme secretion and absorption in the GASTROINTESTINAL TRACT. CCK-A Receptor,Cholecystokinin A Receptor,CCK(1) Receptor,CCK A Receptor,Receptor, CCK-A

Related Publications

B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
April 1997, The American journal of physiology,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
November 1998, Biochemical pharmacology,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
October 1993, Diabetes,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
December 1995, Transplantation proceedings,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
January 1982, Acta biologica et medica Germanica,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
May 1990, Biochemical and biophysical research communications,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
February 2008, PloS one,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
March 2012, Diabetologia,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
November 2007, Biochemical and biophysical research communications,
B T Layden, and V Durai, and M V Newman, and A M Marinelarena, and C W Ahn, and G Feng, and S Lin, and X Zhang, and D B Kaufman, and N Jafari, and G L Sørensen, and W L Lowe
February 2010, Endocrine,
Copied contents to your clipboard!